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The Impact at Stlmulatod Acouatlc Emlrrlon on 
M cardlnl Contrast Echocardlography - Flmt 
CI%cal Rerultn 
#. Inchar, K. llomann, J. KOelar, T, Sohlosaor, Et. Ludoritx. Dapt. Qf 
CUrWofogK unrvera0y or Bonn, Bann, aarmnny 
Prevloua both In.vltro and animal atudlos hava ahown thnt mlorobubblaa ol 
LevovIat4 aot RI actlve aoundnoumos durlnp dlelntogratlon aa they omlt R 
broad band tmquanoy epoctrum (etlmulatod acounlla omlnnlon @A%)), I&J 
totha onset ot SAE It la poealble to recalve Dopplocslgnals oven horn statlon~ 
sty bubbloa or from bubblsa with very low now velo~itIoa. Hence, during their 
apactral charactorlttlcs thoy am beyond the wall litter hequsnclea and have 
a hlgh atgnal amplltudo. However, It In unknown whether SAE le applicable 
In humane to dlaplay myaeardlat contrant atteds. Accardlngly wtt evaluated 
myocardlal sentmat (MC) effents In 3B patlonts with coronary artery dls. 
eaao follawlng Intravenaua balualn(sotlon at 3g t.svovlat, Harmonla Power 
Ropplor Inveatlgatlans (t+PDI) wm performed ualng a modltled aammsr 
slally avatlable ultratound maahlne (HCtl 30ttn, ATt.), tntsmWtsnt aaanninfl 
watt padom’ted ana frame every tYh eardlaa oycla. MC wae aaaeaaed ustng 
a tour atop vlauat score to il no contraat, 3 = oampleta MC). Cantraat atteats 
were evatuatod ualng a callbratou aahwam tool In bath mywnrdntm and 
cavltlert. 
Resulls: MC acorn was 1 .(d t 0.0 ualng uauat tranamlt Pawer (MI 66-t) 
and 2.7 c 0.3 with MI I 1.5 (p .- 6,661). Dallnantlon at myacardlal ccntrast 
tmm contraat slgnala ot the aavltlea was posslbla whlla slgnal Intenaltlos In 
the c ~avltlaa even at the endocardlal banter warn at least 20 tlmea hlgher 
than those et MC. In all mglstrallona contrnat algnats wlthln the l.V-covlty 
appeared at toast 8 oyclaa eartler than MC. MC appoamd always krst in 
basal aeQmenta at the myocardlum. 
Conclusion: t+PDI valth hlgh transmit pawor la usatul tar aaaeaamont ot 
SAE. Thta approach Improvea MC tollawlng Iv lnlackon 01 Lavavrat 
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A New Tlsaue lbrgeted Ultrasound COntraat Agent, 
MRX408 Improves Vlsuall~atlon and Dallneatlon of 
Latt Atrlal Appendage Clot Wlth COnVOt’ttlOttal 
2-dlmenslotidl Echoianllography 
M. lhkeitchl, TP McCreary. K. Dgunyankln. M. Vannan. M. Shonhan. 
R. Connolly, A. Senlanen. E. linger. N. Pandlan. p&s . New Engl MetI 6% 
Raslon, A!A, USA 
Sackgnwnd: Identlkcatlon 01 LA appendage thmmbus (LAAT) has important 
lmpllcatlono. Despdo the utlllty of tranaeaophsgeal echooardtography. mli- 
able rvoognltlon of LAM could be ditkcutt. MRX408. made 01 lipid coaled 
pefflurobutane mlcmbubblea. la a new ultrasound contrasI that largels thmm- 
bus. We hypolhesired that MRX40R would enhance LAAT signals and permrl 
dltterentlatron 01 clot horn adjacent Issue. 
Methods: Tb assess this. we attempted to create In vivo LAAT In 6 dogs 
and lmagod tho hoart wllh convontlonat 2-D ochocardiography al base- 
line. during lnluslon ot a nontargeted contrast. MRXlll and during targeted 
MRX406. LAAT area and Videointensity (VI) were blindly analyzed. Presence 
or absence ot LAAT was verified postmortem. 
Results: (I.4 f SD): In 2 of 6 dogs. them was no contrast enhancement 
01 LAA zone and autopsy showed no clot. In the other 6 dogs, there was 
visually apparent contrast enhancemenl in LAA zone with MRX406 but not 
with MRXll3. Autopsy showed LAAT In all 6. VI ot LAAT In these dogs was 
53.5 f 13.9 at baseline. slightly higher with MRXll3 (79.7 f. 29.5) but was 
much highor with MRX408 (93.9 i 34.4. p < 0.01 vs baseline. p . 0.04 
vs MRXll3). The lull exlont 01 LAAT (area, cm4 was evident with MRX406 
(7.40 f 4.31) when Compared to baseline (3.60 k 2.83, p i 0.02) and 
MRXll3 (4.06 i 2.72, p .z 0.02). 
Conclvsron: MRX406. a thrombus targekng contrast agent, enhances the 
echointensity of LAA clot and demonstrates its extent. It is a promising agont 
for the clinical detection 01 l-AA clot. 
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( 907-3 1 Direct In v/v0 Recording8 of Cavltatlonol Activity 
Wlthln the Antorlor Myocardlum Durln Intennlttent 
and Conventlonal Harmonld lmaalna P 
Intravenous Ultraround Contrast - 
OllOWlItp 
T. Portor, S. Llr 1 C. Evorbach. U~lvmly olN&mska Msdlcaf Ct9nlQc 
$nrnha, Nabfaska, USA: r Swarihnmm Collage. Swarihnmm, ~nnayhranfa, 
Bnckgmurrd: In vlho atudlos have demonatmted that the peak negallve pm& 
nut-en (PNP) used lor dlagnortlc ultrasound lma@ng can produrxr cavttabon 
ot perituonxarbon Illlad ml~mbubbles, but in wvo demons. &n 01 thta has 
never been observed 
Msrhoda: We menamed root mean nquare cavttational acttvtty (CA) wtth a 
26 MHZ alngtn crystal transducer altgned ee that tte tieI reqkxt wae within the 
antsrler myocardktm al two open cheat do@+. The heart wae stmutbmeouaty 
imaged wlth a 1.7 megahertz ham’mnlo transducer usmg PNP of CI.3-0.9 
magapaaoels (MPa) and hams rates (FR) at 43 Hertz (Hr) 10 Hr. and one 
FR every ane (1:l) 10 three (13) cardtao ~~tea (CC). tlat?kgwnd bubtp@ed 
antenar mycwardial vidseintenstty (MVI) wae measured a%kne. tntmvsnous 
(IV) pertluorocarbnn exposed mIcrobubbles tPCG) were m 86 either a 
bolua (p.0025 mlikg) or continuous inlusion (CU. 
Rfwitk4: Resulta are shown (‘p . 0.05 compared to all ather groups): 
n 5-e eMpa 
.x..-- ___ 
MVl~tu”!rst 15 I 7 M , 14 5r f Ifi 81 t 20’ 
CA ~ncmsed aa FR decreased, machtng its masimum at lbe tonpest PFt 
(1 avery 3CC). MVI was dceclty proportional lo CA at 0.9 MPa (f = 0.93. P 
. 0 6961) and 6.5 MPa (r = 0.71; p . 0.991). but dii no1 correlate wtth CA 
when using 0.3 MPa. 
Corrc!usion: In vrvacavrtation 01 PC0 occurs m response to dmgmHrc ut- 
lrasound pressures tmm commercralty available Iransducers. Lwmf Fft and 
higher PNP trkxease intramyccardiat CA ot ~ntrsvenousty injected PCS and 
may be the mechanism lor enhanced myocankal conha wtth intermittent 
harmanic imaging. 
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907-4 Myocardlat Contrast Echocardlogmphy for the 
Detectlon of Coronary Artery Disease 
A. Moraes. F. Morced. A.C. Nogueira. M. Casber. F. Salek. W. Pereea. 
t-t. Dohmann. Hospital plo-Cardraco & ECOR Rro de Jarterra Brarrl 
SacQround: The accuracy 01 mtmvenous (IV) mlusron ot a PESDA sotutron 
(sonicated mrxture ot 1 ml 20% serum atbumm. 12 ml 5% dextrose and 6 ml 
decalluombutane gas), associated to newer ultrasound imaging technques 
to detecl coronary artery disease (CAD) in humans, has not been evatwled 
in a large aortes 01 patients (pts). Accordmgty. we assessed the ability of IV 
PESDA to nmrtuce myccardial conlraat echocardrography (MCE) perfusion 
delocts in pts submitted to coronary angiography (ANG) to investigate CAD. 
Methods: In 92 pls (66 male. 62 f 11 years) submitted to ANG. MCE 
with IV PESDA was obtained usmg ditterent protocols with Second Harmonic 
(St+. Power tiamronic (PH) imaging and triggering mode (TM). ANG was 
normal in 15 pts (Gmup I). with residual lesion <SO?& alter repertusion in 15 
pta (Group II) and wilh obshuclion 60% in 62 pls (Group Ill). To provoke 
a vasodilator response drpyndamole (33 pm) or adenosine (20 pts) were 
used. A homogeneous appearance of contrast enhancement distribution was 
established as normal pedusion pattern (NP). and absence or hetemgeneous 
enhancement as a pedusion detecl (PD). 
Results: MCE showed NP in all except one pl in Group I and had a PD in 
100% of pls in Gmup Ill (in 5 pts only atter stress with diyridamole (3 pts) or 
adenosine (2 pts)). Group II had NP in 9 pls and a PD was detected in 6 pls. 
Conclusion: A PD observed with MCE at rest or after stress stmngly 
correlates with the presence 01 CAD. and may be used to detect CAD in 
humans. 
